Skip to main navigation
Careers
Contact
News
About
Product Pipeline
XEN1101 (FOS)
XEN1101 (PGTCS)
XEN1101 (MDD)
NBI-921352 (NEUROCRINE)
Investors
Header investor menu
Investor Overview
Stock Quote
stock chart
Historic stock lookup
News & Events
Press Releases
Event Calendar
Corporate Governance
Management
BOARD OF DIRECTORS
Committee Composition
FINANCIALS & FILINGS
ANNUAL FINANCIAL REPORTS
Quarterly Results
contact investor relations
Partners
Medical Affairs
Conferences
Publications
Expanded Access Program
About
Product Pipeline
Investors
Partners
Medical Affairs
Careers
Contact
News
Event Details
Xenon Pharmaceuticals Provides Corporate Update (Phase 2 X-NOVA Topline Results)
November 27, 2023 at 8:30 AM EST
Supporting Materials
Webcast slides
1.1 MB
Webcast Presentation
Click here for webcast
Event Details
Title
Xenon Pharmaceuticals Provides Corporate Update (Phase 2 X-NOVA Topline Results)
Date / Time
November 27, 2023 at 8:30 AM EST
Investor Relations
investor overview
stock quote
stock chart
historic stock lookup
Analyst Coverage
news & events
press releases
events calendar
Corporate Governance
Management
Board of Directors
Committee Composition
financials & filings
annual financial reports
Quarterly Results
contact investor relations
Tools
print page
RSS Feeds
e-mail alerts